Sign in

CIK 0001020214 · Accelerated filer

CERUS CORP

Sign in to watch
Ticker
CERS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
680262011
Phone
9252886000
Business address
1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
  1. 4 Planned sale Chief Legal Officer sold 30,000 shares at $2.98 ($89,529)
  2. 4 Planned sale Chief Executive Officer sold 16,666 shares at $3.16 ($52,665)
  3. 4 Planned sale Chief Financial Officer sold 33,676 shares at $2.94 ($99,105)
  4. 4 Planned sale Chief Operating Officer sold 42,359 shares at $2.94 ($124,658)
  5. 4 Planned sale Chief Legal Officer sold 24,329 shares at $2.94 ($71,598)
  6. 4 Planned sale President and CEO sold 101,919 shares at $2.94 ($299,937)
  7. 4 Open-market sale Director sold 20,454 shares at $2.60 ($53,180)
  8. 4 Grant or award Director acquired 60,000 shares (grant or award)
  9. 4 Grant or award Director acquired 60,000 shares (grant or award)
  10. 4 Grant or award Director acquired 60,000 shares (grant or award)
  11. 4 Planned sale Chief Operating Officer sold 16,667 shares at $3.00 ($50,001)
  12. 4 Grant or award Director acquired 60,000 shares (grant or award)
  13. 4 Grant or award Director acquired 60,000 shares (grant or award)
  14. 4 Grant or award Director acquired 60,000 shares (grant or award)
  15. 4 Planned sale Chief Operating Officer sold 16,667 shares at $3.00 ($50,001)
  16. 4 Grant or award Chief Financial Officer acquired 200,000 shares (grant or award)
  17. 4 Grant or award Chief Legal Officer acquired 200,000 shares (grant or award)
  18. 4 Planned sale Chief Legal Officer sold 113,008 shares at $1.66 ($187,277)
  19. 4 Planned sale Chief Operating Officer sold 165,200 shares at $1.66 ($273,769)
  20. 4 Planned sale President and CEO sold 447,757 shares at $1.66 ($742,023)

Page 1 of 36 · 701 filings